Abstract
As more is learned about the natural history of the development of atherosclerosis, it is clear that the process that results in morbidity and mortality in adults has its origins in childhood and adolescence. It is also clear that the traditional risk factors, such as hypertension and dyslipidemia, are important in the early stages of the process. It appears that the prevalence and severity of obesity are increasing in children and adolescents in the United States. This trend is associated with increasing blood pressure and the occurrence of type 2 diabetes mellitus in young individuals. These trends may result in increased cardiovascular morbidity and mortality as these overweight pediatric patients become obese adults. Intervention and prevention strategies should be directed at the pediatric population as a whole, as well as at higher-risk individuals. For the latter, it will be necessary to identify those at highest risk. Both nonpharmacologic and pharmacologic approaches may be necessary for treatment of pediatric patients with hyperlipidemia and hypertension. Studies are needed that evaluate the longer-term impact of intervention on cardiovascular risk factors in young patients.
Similar content being viewed by others
References and Recommended Reading
Klotz O, Manning MF: Fatty streaks in the intima of arteries. J Pathol Bacteriol 1911, 16:211.
Aschoff L: Atherosclerosis in Lectures on Pathology. New York: Hoeber; 1924:131–153.
Enos WF, Holmes RH, Beyer J: Coronary disease among United States soldiers killed in action in Korea: preliminary report. JAMA 1953, 152:1090–1093.
McNamara JJ, Molot MA, Stremple JF, Cutting RT: Coronary artery disease in combat casualties in Vietnam. JAMA 1971, 7:1185–1187.
Tuzcu EM, Kapadia SR, Tutar E, et al.: High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults. Circulation 2001, 103:2705–2710.
PDAY Research Group: Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990, 264:3018–3024.
McGill HC, McMahan CA, Zieske AW, et al., for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group: Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 2001, 103:1546–1550.
Newman WP III, Freedman DS, Voors AW, et al.: Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. N Engl J Med 1986, 314:138–144.
Berenson GS, Srinivasan SR, Bao W, et al., for the Bogalusa Heart Study: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998, 338:1650–1656.
Mahoney LT, Burns TL, Stanford W, et al.: Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol 1996, 27:277–284.
Eckel RH, Krauss RM: American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998, 21:2099–2100.
Luepker RV, Jacobs DR, Prineas RJ, Sinaiko AR: Secular trends of blood pressure and body size in a multi-ethnic adolescent population: 1986 to 1996. J Pediatr 1999, 134:668–674.
Morrison JA, James FW, Sprecher DL, et al.: Sex and race differences in secular trends in cardiovascular disease risk factors in school children: The Princeton School Study 1975–1990. Am J Pub Health 1999, 89:1708–1714.
Ogden CL, Troiano RP, Briefel RR, et al.: Prevalence of overweight among preschool children in the United States 1971 through 1994. Pediatrics 1997, 99:E1.
Troiano RP, Flegal KM, Kuczmarski RJ, et al.: Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 1995, 149:1085–1091.
Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al.: Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective. J Pediatr 2000, 136:664–672.
Pinhas-Hamiel O, Dolan LM, Daniels SR, et al.: Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996, 128:608–615.
Adelman RD, Restaino IG, Alon US, Blowey DL: Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001, 138:481–485.
Welch TR, Daniels SR: Yet another target organ of obesity. J Pediatr 2001, 138:455–456.
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049–1057.
Morrison JA, Jacobsen DW, Sportier DL, et al.: Serum glutathione in adolescent males predicts parental coronary heart disease. Circulation 1999, 100:2244–2247.
Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973–979.
Visser M, Bouter LM, McQuillan GM, et al.: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131–2135.
Ford ES, Galuska DA, Gillespie C, et al.: C-reactive protein and body mass index in children: Findings from the Third National Health and Nutrition Examination Survey, 1988–1994. J Pediatr 2001, 138:486–492.
Levy D, Garrison RJ, Savage DD, et al.: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561–1566.
deSimone G, Devereux RB, Daniels SR, et al.: Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995, 25:1056–1062.
Daniels SR, Loggie JM, Khoury P, Kimball TR: Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998, 97:1907–1911.
Ganau A, Devereux RB, Roman MJ, et al.: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550–1558.
Whitaker RC, Wright JA, Pepe MS, et al.: Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997, 337:869–873.
Steinberger J, Moran A, Hong CP, et al.: Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J Pediatr 2001, 138:469–473.
Morrison JA, Barton BA, Biro FM, et al.: Overweight, fat patterning and cardiovascular disease risk factors in black and white boys. J Pediatr 1999, 135:451–457.
Morrison JA, Sprecher DL, Barton BA, et al.: Overweight, fat patterning and cardiovascular disease risk factors in black and white girls: The National Heart, Lung and Blood Institute Growth and Health Study. J Pediatr 1999, 135:458–464.
Lauer RM, Lee J, Clarke WR: Factors affecting the relationship between childhood and adult cholesterol levels: The Muscatine Study. Pediatrics 1988, 82:308–318.
Lauer RM, Clarke WR: Childhood risk factors for high adult blood pressure: The Muscatine Study. Pediatrics 1989, 84:633–641.
Barker DJ, Gluckman PD, Godfrey KM, et al.: Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341:938–941.
Osmond C, Barker DJ, Winter PD, et al.: Early growth and death from cardiovascular disease in women. BMJ 1993, 307:1519–1524.
Hales CN, Barker DJ, Clark PM, et al.: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991, 303:1019–1022.
Barker DJ, Osmond C, Golding J, et al.: Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989, 298:564–567.
Donker GA, Labarthe DR, Harrist RB, et al.: Low birth weight and blood pressure at age 7–11 years in a biracial sample. Am J Epidemiol 1997, 145:387–397.
Hinchcliffe S: The effect of intrauterine growth retardation on the development of renal nephrons. Br J Ob Gyn 1992, 99:296–304.
Desai M, Hales C: Role of fetal and infant growth in programming metabolism in later life. Biol Rev 1997, 72:329–348.
Barlow SE, Dietz WH: Obesity evaluation and treatment: Expert Committee recommendations: The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 1998, 102:E29.
American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992, 89(3 Pt 2):525–584.
Obarzanek E, Kimm SY, Barton BA, et al., for the DISC Collaborative Research Group: Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven year results of the Dietary Intervention Study in Children (DISC). Pediatrics 2001, 107:256–264.
Sprecher DL, Daniels SR: Rational approach to pharmacologic reduction of cholesterol levels in children. J Pediatr 1996, 129:4–7.
Report of the Second Task Force on Blood Pressure Control in Children-1987.Pediatrics 1987, 79:1–25.
Roccella EJ, Anderson DE: Update on the Task Force Report (1987) on High Blood Pressure in Children and Adolescents: A Working Group Report from the High Blood Pressure Education Program. Pediatrics 1996, 98:649–658.
Jones DW, Frohlich ED, Grim CM, et al.: Mercury sphygmomanometers should not be abandoned: an advisory statement from the Council for High Blood Pressure Research, American Heart Association. Hypertension 2001, 37:185–186.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daniels, S.R. Cardiovascular disease risk factors and atherosclerosis in children and adolescents. Curr Atheroscler Rep 3, 479–485 (2001). https://doi.org/10.1007/s11883-001-0038-3
Issue Date:
DOI: https://doi.org/10.1007/s11883-001-0038-3